TAG of the Week: The Cost for Life
If you are a policymaker and you've read that screening for Lynch Syndrome can save lives and money in the long-run, what pieces of evidence would you like the article from BioTech Now to present to you in order for you to assess whether a program can use this information in the near future? Now as an engineer in a biotech company looking into cancer-related genetic markers, what do you think will support and enhance future research goals? Do you agree or disagree with the court ruling as an engineer? What ways can both financially support the interests of venture capitalists and biotech companies while keeping these tests accessible to those who need it? Do you think a change in health policy planning must be involved in regulating costs?
If you are a policymaker and you've read that screening for Lynch Syndrome can save lives and money in the long-run, what pieces of evidence would you like the article from BioTech Now to present to you in order for you to assess whether a program can use this information in the near future? Now as an engineer in a biotech company looking into cancer-related genetic markers, what do you think will support and enhance future research goals? Do you agree or disagree with the court ruling as an engineer? What ways can both financially support the interests of venture capitalists and biotech companies while keeping these tests accessible to those who need it? Do you think a change in health policy planning must be involved in regulating costs?
http://www.biotech-now.org/
(some background) - http://www.cmaj.ca/cgi/